The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adverse events and their management in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, after longer-term follow-up from the global phase 3 MANEUVER trial.
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Daiichi Sankyo; Deciphera; Deciphera; EMD Serono; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Deciphera (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo; EMD Serono/Merck
 
Vishal Ghori
Employment - Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany
Stock and Other Ownership Interests - Incyte; Merck
 
Aimar Zhang
Employment - Merck Serono
 
Niki Karachaliou
No Relationships to Disclose
 
Hans Gelderblom
Research Funding - Abbisko Therapeutics (Inst); AmmaxBio (Inst); Blueprint Medicines (Inst); Deciphera (Inst); InhibRx (Inst); Ipsen (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Merck (Inst)
 
Qingping Zou
Employment - Abbisko Therapeutics
 
Boyao Shan
Employment - Abbisko Therapeutics
 
Xiaohui Niu
No Relationships to Disclose